4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid

Product Overview

4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid is a specialized organic compound serving as a critical building block in the pharmaceutical industry. With the CAS registry number 179162-55-1, this substance is primarily utilized as a key intermediate in the synthesis of advanced antifungal agents. Our manufacturing facility ensures that every batch meets rigorous chemical standards, providing researchers and production teams with a reliable source of high-quality material for complex organic synthesis pathways.

As a dedicated chemical supplier, we understand the importance of consistency in pharmaceutical manufacturing. This benzoic acid derivative is produced using optimized reaction conditions to maximize yield and purity. The molecular structure, characterized by the isoxazole ring and pentyloxyphenyl group, requires precise handling and purification processes to ensure it meets the demanding specifications required for downstream drug production.

Quality Specifications

Quality assurance is the cornerstone of our production process. Each lot undergoes comprehensive analytical testing using high-performance liquid chromatography (HPLC) and other validated methods. We maintain strict control over impurities and residual solvents to ensure safety and efficacy in subsequent synthesis steps. The following table outlines the typical specification profile for this product:

Industrial Applications

This chemical intermediate plays a vital role in the manufacturing of sophisticated pharmaceutical compounds. Specifically, it serves as a precursor in the production pathway of Micafungin, a well-known antifungal medication. The high purity level of our product ensures that the final active pharmaceutical ingredient (API) meets regulatory standards for safety and potency. Beyond this specific application, the compound's unique structural features make it valuable for various research and development projects focused on heterocyclic chemistry and medicinal organic synthesis.

Our clients utilize this material for scale-up processes, method validation, and commercial production. By providing a consistent supply chain, we support the continuous manufacturing needs of pharmaceutical companies worldwide. The robust quality control measures implemented during production minimize batch-to-batch variability, which is crucial for maintaining regulatory compliance in drug manufacturing.

Storage and Handling

To maintain the integrity of 4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid, proper storage conditions are essential. The material should be kept in a cool, ventilated area away from direct sunlight and moisture. Containers must be tightly sealed to prevent contamination or degradation. We recommend following standard laboratory safety protocols when handling this substance, including the use of appropriate personal protective equipment. Our packaging options include 25 kg drums, with custom packaging available upon request to suit specific logistical requirements.